CTI BioPharma Corp. (CTIC) |
| 9.095 0.005 (0.06%) 06-23 15:58 |
| Open: | 9.1 |
| High: | 9.1 |
| Low: | 9.09 |
| Volume: | 5,558,437 |
| Market Cap: | 1,199(M) |
| PE Ratio: | -16.84 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.31 |
| Resistance 1: | 10.39 |
| Pivot price: | 9.60 |
| Support 1: | 8.90 |
| Support 2: | 7.40 |
| 52w High: | 9.1 |
| 52w Low: | 4.01 |
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
Financials
| EPS | -1.250 |
| Book Value | 9.610 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.469 |
| Profit Margin (%) | -4.33 |
| Operating Margin (%) | 2.58 |
| Return on Assets (ttm) | 0.6 |
| Return on Equity (ttm) | -3.5 |
Company news
Tue, 30 May 2023
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders - PR Newswire
Wed, 10 May 2023
Sobi to Acquire CTI BioPharma - PR Newswire
Mon, 10 Apr 2023
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Mon, 06 Mar 2023
CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results - PR Newswire
Thu, 05 Jan 2023
CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference - PR Newswire
Mon, 07 Nov 2022
CTI BioPharma Reports Third Quarter 2022 Financial Results - PR Newswire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
